Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia

Affiliations

• ¹ Harvard Stem Cell Institute, Harvard Medical School, Boston, USA.
• ² Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
• ³ Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
• ⁴ Discipline of Medicine, University of Adelaide, Adelaide, Australia.
• ⁵ Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University, Stanford, USA.
• ⁶ Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
• ⁷ Diamantina Institute, Translational Research Institute, Brisbane, Australia.
• ⁸ Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.
• ⁹ Metabolomics Australia, The University of Melbourne, Melbourne, Australia.
• ¹⁰ Adelaide Oncology & Haematology, Adelaide, Australia.
• ¹¹ Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
• ¹² Department of Clinical Haematology, Royal Adelaide Hospital, Adelaide, Australia.
• ¹³ School of Pharmacy, University of Queensland, Brisbane, Australia.
• ¹⁴ Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia. Richard.DAndrea@unisa.edu.au.